In the 2nd part of a new SPM interview series, Charles Serhan, PhD, DSc answers the question: “Can you describe some therapeutic areas where specialized pro-resolving mediators are currently being investigated for clinical use?” Dr. Serhan discusses the most current therapeutic research assessing SPM efficacy, including pulmonary, cardiometabolic, vascular, joint and cognitive health, as well as pain and wound healing. Charles Serhan, PhD, DSc is Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital…
In the 2nd part of a new SPM interview series, Charles Serhan, PhD, DSc answers the question: “Can you describe some therapeutic areas where specialized pro-resolving mediators are currently being investigated for clinical…
In the 3rd part of a new SPM interview series, Charles Serhan, PhD, DSc answers the question: “Are there any recent findings or results in resolvins research that have surprised you?” Dr. Serhan discusses the recently discovered resolution role of specialized pro-resolving mediators (SPMs) in the adaptive immune response, including the regulation of B cell function and facilitating antibody production. Charles Serhan, PhD, DSc is Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital…
In the 3rd part of a new SPM interview series, Charles Serhan, PhD, DSc answers the question: “Are there any recent findings or results in resolvins research that have surprised you?” Dr. Serhan…
In the 4th part of the SPM interview series with Charles Serhan, PhD, DSc, he answers the question: “Besides peripheral blood, can pro-resolving mediators be measured in other tissues? If so, which ones?” Dr. Serhan shares current research findings on SPM measurement in the human body, demonstrating several human tissues and fluids where SPMs have been found. These discoveries will directly inform analytical methods for SPM measurement moving forward. Dr. Serhan also discusses the “coagulation clock”, as well as gender-…
In the 4th part of the SPM interview series with Charles Serhan, PhD, DSc, he answers the question: “Besides peripheral blood, can pro-resolving mediators be measured in other tissues? If so, which ones?”…
In the 5th part of the SPM interview series with Charles Serhan, PhD, DSc, he explores the latest research to answer the question: “What is the role of resolvins in cancer?” Listen in as Dr. Serhan shares the impact resolvins have on tumor debris clearance, tumor burden and cytotoxic agent use in animal models, as well as the potential for applications in human oncologic treatment. Charles Serhan, PhD, DSc is Director of the Center for Experimental Therapeutics and Reperfusion Injury…
In the 5th part of the SPM interview series with Charles Serhan, PhD, DSc, he explores the latest research to answer the question: “What is the role of resolvins in cancer?” Listen in…
In the 6th part of the SPM interview series, Charles Serhan, PhD, DSc provides insights into the query: “What role do you envision lipid mediators and active resolution will play in future clinical decision-making?” Dr. Serhan shares an edifying history on resolvins, from molecular work following their discovery in 2000, to the growing body of in vivo animal model results in inflammatory and infection processes, and now to the ongoing human clinical studies. Charles Serhan, PhD, DSc is Director of the…
In the 6th part of the SPM interview series, Charles Serhan, PhD, DSc provides insights into the query: “What role do you envision lipid mediators and active resolution will play in future clinical decision-making?”…
Gail Cresci, PhD, RD, LD, CNSc: The Gut Microbiome in Health and Disease 2-part series, "Therapeutic Manipulations of Gut Microbiota – Module 2" In this module Dr. Gail Cresci discusses the therapeutic manipulations of gut microbiota, including methods for managing peptic ulcers. Dr. Cresci explores the use of fecal microbiota transplants to manage recurrent C. difficile infection, as well as the benefits of pre- and probiotics for specific ailments. Dr. Cresci’s research examines the desirable properties of specific probiotic strains, their…
Gail Cresci, PhD, RD, LD, CNSc: The Gut Microbiome in Health and Disease 2-part series, "Therapeutic Manipulations of Gut Microbiota – Module 2" In this module Dr. Gail Cresci discusses the therapeutic manipulations of…
Gail Cresci, PhD, RD, LD, CNSc: The Gut Microbiome in Health and Disease 2-part series, “Diversity of the Gut Microbiota and the Host – Module 1” In this module Dr. Gail Cresci discusses the diversity of the gut microbiome and its influences on the host, as well as the associations of gut dysbiosis and synbiosis. Dr. Cresci's research has led to a greater understanding of the impact of the gut microbiota on metabolism, gene expression and immune function, as well…
Gail Cresci, PhD, RD, LD, CNSc: The Gut Microbiome in Health and Disease 2-part series, “Diversity of the Gut Microbiota and the Host – Module 1” In this module Dr. Gail Cresci discusses…
In this presentation Gail Cresci, PhD, RD reviews how digestive health is enhanced when the gut microbiome is rich in diverse micro flora. This diversity is supported when preferred energy sources for the bacteria are available and support the viability of microbiota. The importance of these combinations lies in the fact that a metabolic environment is created which in turns provides protection of the gut barrier, optimal immune response and normal gut function and influences on a variety of other…
In this presentation Gail Cresci, PhD, RD reviews how digestive health is enhanced when the gut microbiome is rich in diverse micro flora. This diversity is supported when preferred energy sources for the…
In this video, Gail Cresci, PhD, RD, LD, CNSC from the Cleveland Clinic discusses the microbiome and whether synbiotics, synergistic combination of pre- and probiotics, make a difference. She covers the rationale for synbiotic use, synbiotic approaches, supporting evidence for health outcomes. Presented at ASPEN Clinical Nutrition Week 2015. View the Slide Deck
In this video, Gail Cresci, PhD, RD, LD, CNSC from the Cleveland Clinic discusses the microbiome and whether synbiotics, synergistic combination of pre- and probiotics, make a difference. She covers the rationale for…
Rob Knight, PhD is a pioneer in the study of microbiomes, in humans, animals, and the environment. He says “the three pounds of microbes that you carry around with you might be more important than every single gene you carry around in your genome.” Dr. Knight is the author of a popular TED book, Follow Your Gut: The Enormous Impact of Tiny Microbes, which explores how microbes impact your health, mood, and more. In this TED Talk, Dr. Knight discusses…
Rob Knight, PhD is a pioneer in the study of microbiomes, in humans, animals, and the environment. He says “the three pounds of microbes that you carry around with you might be more…